Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApq Global Regulatory News (APQ)

Share Price Information for Apq Global (APQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.50
Bid: 4.00
Ask: 7.00
Change: 0.00 (0.00%)
Spread: 3.00 (75.00%)
Open: 5.50
High: 5.50
Low: 5.50
Prev. Close: 5.50
APQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New appointment to Advisory Council

12 Oct 2017 07:00

RNS Number : 3395T
APQ Global Limited
12 October 2017
 

12 October 2017

APQ Global Limited

("APQ Global" or the "Company")

New appointment to Advisory Council

APQ Global, the emerging markets income company, is pleased to announce that it has made a further appointment to its International Advisory Council ('IAC') with Gregory Van den Bergh who will focus on opportunities in China.

Gregory Van den Bergh is the co-founder and CEO of MiCai, a financial technology company for wealth management firms which was established in 2014. Prior to MiCai, Gregory worked for the Emerging Markets fund of GLG Partners (purchased by MAN Group), a hedge fund with 26bn USD under management. Gregory also has experience working on the Emerging Markets Principal Trading desk at Citi and at Private Wealth Management at Morgan Stanley in Hong Kong. Greg has a B.A. in Philosophy and Modern Languages from Oxford University, where he studied Philosophy and Chinese. He taught at Harvard University and has an MBA from the Cheung Kong Graduate School of Business.

Tania Rotherwick, Chairwoman of APQ Global's International Advisory Council commented: "We are pleased that Gregory has agreed to join our now eleven strong team of advisors on APQ Global's International Advisory Council. His experience in Chinese markets will be of huge benefit as we seek to continue to explore exciting opportunities across Asia. The provision of local insights across emerging markets is helping to shape APQ Global's business strategy of delivering stable income to shareholders."

 

-End -

Enquiries:

APQ Global LimitedBart Turtelboom - Chief Executive Officer

020 3478 9708

 

 

N+1 Singer - Nominated Adviser and BrokerJames Maxwell / Lauren Kettle

020 7496 3000

 

 

Carey Group - CISE sponsorMatt Sarl

01481 737 279

 

Buchanan Communication - Financial PRCharles Ryland / Victoria Hayns

020 7466 5000

 

 

 

Notes to Editors

APQ Global Limited

APQ Global (ticker: APQ LN) is a global emerging markets income company with interests across Asia, Latin America, Eastern Europe, the Middle East and Africa. The Company's objective is to steadily grow earnings to deliver attractive returns and capital growth to shareholders. This objective is achieved through a combination of revenue generating operating activities and investing in growing businesses across emerging markets. APQ Global run a well-diversified and liquid portfolio, take strategic stakes in selected businesses and plan to take operational control of companies through the acquisition of minority and majority stakes in companies with a focus on emerging markets.

For more information, please visit apqglobal.com.

International Advisory Council (IAC)

Established in February 2017, the IAC assists in locating the best investment opportunities across the globe. The panel of advisors, chaired by Tania Rotherwick, contribute insights from their own areas of geographical and sector expertise to support APQ Global's business strategy.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFFIFFFFWSEIS
Date   Source Headline
13th Jun 20244:30 pmRNSChange of Registered Office
24th May 20247:00 amRNSBook Value Report
3rd Apr 20247:00 amRNSTrading Update
22nd Mar 20247:00 amRNSBook Value Report
6th Feb 20245:00 pmRNSBook Value Report
19th Dec 20235:00 pmRNSBook Value Report
20th Nov 20235:06 pmRNSBook Value Report
17th Oct 20235:00 pmRNSBook Value Report
27th Sep 202312:00 pmRNSBook Value Report
21st Sep 20231:00 pmRNSDirectorate Change
17th Aug 20235:00 pmRNSBook Value Report
9th Aug 20235:01 pmRNSResult of AGM
14th Jul 20231:00 pmRNSBook Value Report
10th Jul 202312:00 pmRNSNotice of AGM
22nd Jun 20231:00 pmRNSBook Value Report
6th Jun 20237:00 amRNSFinal results for the year to 31 December 2022
17th May 20231:00 pmRNSBook Value Report
20th Apr 202310:00 amRNSResult of Tender Offer for CULS
18th Apr 20237:00 amRNSBook Value Report
3rd Apr 20237:00 amRNSTender Offer for CULS
17th Mar 20237:00 amRNSBook Value Report
21st Feb 20239:00 amRNSBook Value Report
27th Jan 20237:00 amRNSBook Value Report
16th Dec 20225:00 pmRNSBook Value Report
16th Nov 20225:00 pmRNSBook Value Report
17th Oct 20227:00 amRNSBook Value Report
17th Oct 20227:00 amRNSBook Value Report
4th Oct 20227:00 amRNSIssue of Equity and PDMR/Director Shareholding
29th Sep 20227:00 amRNSInterim results for six months ended 30 June 2022
14th Sep 20221:00 pmRNSBook Value Report
16th Aug 202212:00 pmRNSBook Value Report
15th Aug 20224:00 pmRNSChange of Registered Office
10th Aug 202211:00 amRNSResult of AGM
25th Jul 20227:00 amRNSIssue of Equity and PDMR/Director Shareholding
15th Jul 202212:30 pmRNSBook value report
11th Jul 20227:00 amRNSNotice of AGM
16th Jun 20227:00 amRNSBook Value Report
1st Jun 20227:00 amRNSFinal results for the year to 31 December 2021
19th May 20227:00 amRNSBook Value Report
27th Apr 20227:00 amRNSIssue of Equity and PDMR/Director Shareholding
14th Apr 20228:00 amRNSQuarterly Update
14th Apr 20227:00 amRNSBook Value Report
15th Mar 20227:00 amRNSBook Value Report
21st Feb 20227:00 amRNSBook Value Report
28th Jan 20227:00 amRNSBook Value Report
21st Jan 20227:00 amRNSIssue of Equity and PDMR/Director Shareholding
20th Dec 20217:00 amRNSBook Value Report
17th Nov 20217:00 amRNSBook Value Report
11th Nov 20217:00 amRNSRepurchase of Convertible Preference Shares
9th Nov 20217:00 amRNSRepurchase of Convertible Preference Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.